“gilead-sciences” Archives

in
Entry Author Date Location
At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place 11/16/17 Seattle
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Landos Joins Garabedian’s Bio Startup Accelerator Xontogeny, Gets $10M 09/21/17 Boston
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Report: Martin Shkreli Faces Prison Term After Fraud Conviction 08/04/17 New York
Booster Fills Up With $20M for On-Demand Gas—Is It ‘Sustainable’? 08/01/17 San Francisco
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Page 1 of 10 next page »